Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.0033 | 1 |
mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.0048 | 1 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.00052 | 1 |